Kyoko Arai

1.2k total citations
53 papers, 1.0k citations indexed

About

Kyoko Arai is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kyoko Arai has authored 53 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 18 papers in Oncology and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kyoko Arai's work include Cancer Immunotherapy and Biomarkers (10 papers), Renal cell carcinoma treatment (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Kyoko Arai is often cited by papers focused on Cancer Immunotherapy and Biomarkers (10 papers), Renal cell carcinoma treatment (7 papers) and Bladder and Urothelial Cancer Treatments (7 papers). Kyoko Arai collaborates with scholars based in Japan, United Kingdom and United States. Kyoko Arai's co-authors include Ken‐Ichiro Yoshida, Takao Kamai, Hideyuki Abe, Misao Ohki, Yasuhito Arai, Fumie Hosoda, Fumiko Morohoshi, Shuhei Sumi, Akira Tanigami and Yasuhiko Kaneko and has published in prestigious journals such as Blood, Cancer and Scientific Reports.

In The Last Decade

Kyoko Arai

52 papers receiving 1.0k citations

Peers

Kyoko Arai
Fumihiko Matsuno Japan
John M. Garland United Kingdom
Robert Tressler United States
D. Fan United States
Evelyn N. Garrett United States
Amy E. Birsner United States
Kanji Hojo Japan
Elena G. Arias‐Salgado Spain
Lorena Lôbo de Figueiredo-Pontes Brazil
Sarah Attwell United States
Fumihiko Matsuno Japan
Kyoko Arai
Citations per year, relative to Kyoko Arai Kyoko Arai (= 1×) peers Fumihiko Matsuno

Countries citing papers authored by Kyoko Arai

Since Specialization
Citations

This map shows the geographic impact of Kyoko Arai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kyoko Arai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kyoko Arai more than expected).

Fields of papers citing papers by Kyoko Arai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kyoko Arai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kyoko Arai. The network helps show where Kyoko Arai may publish in the future.

Co-authorship network of co-authors of Kyoko Arai

This figure shows the co-authorship network connecting the top 25 collaborators of Kyoko Arai. A scholar is included among the top collaborators of Kyoko Arai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kyoko Arai. Kyoko Arai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kijima, Toshiki, et al.. (2023). Increased co-expression of stromal HHLA2 and fibroblast activation protein in upper tract urothelial carcinoma. International Urology and Nephrology. 55(4). 867–874. 4 indexed citations
2.
3.
Asano, Ryutaro, S. KONNO, Hiromi Ogata, et al.. (2020). Build-up functionalization of anti-EGFR × anti-CD3 bispecific diabodies by integrating high-affinity mutants and functional molecular formats. Scientific Reports. 10(1). 4913–4913. 5 indexed citations
4.
Masuda, Akinori, Kyoko Arai, Tomoya Mizuno, et al.. (2014). Clinical Significance of Serum Soluble T Cell Regulatory Molecules in Clear Cell Renal Cell Carcinoma. BioMed Research International. 2014. 1–6. 20 indexed citations
5.
6.
Masuda, Akinori, Takao Kamai, Hideyuki Abe, Kyoko Arai, & Ken‐Ichiro Yoshida. (2009). Is Stat3 and/or p53 mRNA expression a prognostic marker for renal cell carcinoma?. Biomedical Research. 30(3). 171–176. 18 indexed citations
7.
Abe, Hideyuki, Takao Kamai, Hiromichi Shirataki, et al.. (2008). High expression of Ran GTPase is associated with local invasion and metastasis of human clear cell renal cell carcinoma. International Journal of Cancer. 122(10). 2391–2397. 58 indexed citations
8.
Abe, Hideyuki, et al.. (2008). Significant association of interleukin 10 receptor mRNA levels with renal cell carcinoma metastasis. Biomedical Research. 29(1). 19–25. 6 indexed citations
9.
Koga, Fumitaka, Satoshi Kitahara, Kyoko Arai, et al.. (2000). Negative p53/Positive p21 Immunostaining Is a Predictor of Favorable Response to Chemotherapy in Patients with Locally Advanced Bladder Cancer. Japanese Journal of Cancer Research. 91(4). 416–423. 17 indexed citations
10.
Arai, Yasuhito, Akira Tanigami, Yoshinori Murakami, et al.. (1999). A 2-Mb Sequence-Ready Contig Map and a Novel Immunoglobulin Superfamily Gene IGSF4 in the LOH Region of Chromosome 11q23.2. Genomics. 62(2). 139–146. 108 indexed citations
11.
Morohoshi, Fumiko, Kyoko Arai, Hitoshi Ichikawa, et al.. (1998). Genomic structure of the human RBP56/hTAF68 and FUS/TLS genes. Gene. 221(2). 191–198. 81 indexed citations
12.
Yoshida, Ken‐ichiro, Shuhei Sumi, Kyoko Arai, et al.. (1997). Serum concentration of type I collagen metabolites as a quantitative marker of bone metastases in patients with prostate carcinoma. Cancer. 80(9). 1760–1767. 1 indexed citations
13.
14.
Arai, Kyoko & Takeshi Yokota. (1993). In vitro antibacterial activity of cefozopran. Chemotherapy. 41. 11–19. 1 indexed citations
15.
Yokota, Takeshi, et al.. (1992). Levofloxacin (DR-3355) の試験管内抗菌力・動物細胞に対する選択毒性および神経突起に対する影響. Chemotherapy. 40(3). 27–35. 2 indexed citations
16.
Yokota, Takeshi, Eiko Suzuki, & Kyoko Arai. (1989). Cefdinir, its in vitro antibacterial activity, binding affinity to bacterial PBPs, stability to, β-lactamases, and synergy of bactericidal effect with serum complement and mouse cultured macrophages. Chemotherapy. 37. 16–29.
17.
Yokota, Takeshi, Ryushi Nozawa, Eiko Suzuki, & Kyoko Arai. (1988). Cefodizime (THR-221), its in vitro antibacterial activity, binding affinity to bacterial PBPs, and synergy of bactericidal activity with complement and mouse cultured macrophages. Chemotherapy. 36(5). 60–76. 2 indexed citations
18.
Yokota, Takeshi, et al.. (1988). T-3262, A new quinolone derivative: Its in vitro antibacterial activity, influence of serum protein on the activity, cytotoxicity, and synergy of bactericidal effect with mouse cultured macrophages. Chemotherapy. 36. 19–29. 1 indexed citations
19.
Yokota, Takeshi, et al.. (1987). A New Oxacephem, 6315-S (Flomoxef), Its Antibacterial Activity In Vitro, Stability To β-Lactamases, Binding-Affinity To Penicillin-Binding Proteins, And Synergy Of Bactericidal Effect With Serum Complement And Cultured Macrophages. Chemotherapy. 35. 33–43. 2 indexed citations
20.
Koyama, Iwao, Kyoko Arai, Yoshikatsu Sakagishi, Hiroh Ikezawa, & Tsugikazu Komoda. (1987). Blood appearance of rat alkaline phosphatase originating from the duodenum in vitro. Journal of Chromatography B Biomedical Sciences and Applications. 420(2). 275–286. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fumihiko Matsuno Breakdown of academic impact, for papers by John M. Garland Breakdown of academic impact, for papers by Robert Tressler Breakdown of academic impact, for papers by D. Fan Breakdown of academic impact, for papers by Evelyn N. Garrett Breakdown of academic impact, for papers by Amy E. Birsner Breakdown of academic impact, for papers by Kanji Hojo Breakdown of academic impact, for papers by Elena G. Arias‐Salgado Breakdown of academic impact, for papers by Lorena Lôbo de Figueiredo-Pontes Breakdown of academic impact, for papers by Sarah Attwell
Rankless by CCL
2026